Zobrazeno 1 - 10
of 234
pro vyhledávání: '"BM Wolpin"'
Autor:
Manuel Hidalgo, D Easton, William Greenhalf, Paige M. Bracci, Víctor Manuel Barberá, Alan A. Arslan, Enrique Dominguez-Munoz, Isabel Adoración Martín-Antoniano, Luis Arnes, L. Ilzarbe, Rita T. Lawlor, Stephen J. Chanock, Marc A. Marti-Renom, Luis Muñoz-Bellvís, LT Amundadottir, BM Wolpin, M Gunter, F.X. Real, L Beane-Freeman, Josefina Mora, Jörg Kleeff, PJ Goodman, Tatjana Crnogorac-Jurcevic, Juan Antonio Rodríguez, B Kong, K Visvanathan, Harvey A. Risch, S Gallinger, Debra T. Silverman, O Lao, Joaquim Balsells, Damian O'Driscoll, M O’Rorke, Núria Malats, D Albanes, A. Carrato, Epicuro Investigators, Eithne Costello, RZ Stolzenberg-Solomon, Esther Molina-Montes, PanGenEU Study Investigators, Xavier Molero, RE Neale, Paulina Gomez-Rubio, Thornquist, Weimin Ye, Nathanial Rothman, Xiao-Ou Shu, Laura C. Alonso, Ulrike Peters, Mirari Marquez, Wei Zheng, Aldo Scarpa, Ll Cecchini, Thomas M. Gress, Alison P. Klein, F Canzian, D Li, Adonina Tardón, A Farré, Manolis Kogevinas, M Garcia-Closas, GM Petersen, B Bueno-de-Mesquita, Mar Iglesias, MJ Sánchez, José Perea, Christoph W. Michalski, M Du, Linda Sharp, JM Gaziano, Matthias Löhr, J Yu, L LeMarchand, J Buring, E. López de Maturana, Paul Brennan
Publikováno v:
GENOME MEDICINE
r-FISABIO. Repositorio Institucional de Producción Científica
instname
López de Maturana, E, Rodríguez, J A, Alonso, L, Lao, O, Molina-Montes, E, Martín-Antoniano, I A, Gómez-Rubio, P, Lawlor, R, Carrato, A, Hidalgo, M, Iglesias, M, Molero, X, Löhr, M, Michalski, C, Perea, J, O’Rorke, M, Barberà, V M, Tardón, A, Farré, A, Muñoz-Bellvís, L, Crnogorac-Jurcevic, T, Domínguez-Muñoz, E, Gress, T, Greenhalf, W, Sharp, L, Arnes, L, Cecchini, L, Balsells, J, Costello, E, Ilzarbe, L, Kleeff, J, Kong, B, Márquez, M, Mora, J, O’Driscoll, D, Scarpa, A, Ye, W, Yu, J, García-Closas, M, Kogevinas, M, Rothman, N, Silverman, D T, Albanes, D, Arslan, A A, Beane-Freeman, L, Bracci, P M, Brennan, P, Bueno-de-Mesquita, B, Buring, J, Canzian, F, PanGenEU Investigators & SBC/EPICURO Investigators 2021, ' A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer ', Genome Medicine, vol. 13, no. 1, 15 . https://doi.org/10.1186/s13073-020-00816-4
Genome Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
PanGenEU Investigators & SBC/EPICURO Investigators 2021, ' A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer ', genome medicine, vol. 13, no. 1, pp. 15 . https://doi.org/10.1186/s13073-020-00816-4
Genome Medicine, Vol 13, Iss 1, Pp 1-18 (2021)
WOS:000616492900001
RUO. Repositorio Institucional de la Universidad de Oviedo
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-FISABIO. Repositorio Institucional de Producción Científica
instname
López de Maturana, E, Rodríguez, J A, Alonso, L, Lao, O, Molina-Montes, E, Martín-Antoniano, I A, Gómez-Rubio, P, Lawlor, R, Carrato, A, Hidalgo, M, Iglesias, M, Molero, X, Löhr, M, Michalski, C, Perea, J, O’Rorke, M, Barberà, V M, Tardón, A, Farré, A, Muñoz-Bellvís, L, Crnogorac-Jurcevic, T, Domínguez-Muñoz, E, Gress, T, Greenhalf, W, Sharp, L, Arnes, L, Cecchini, L, Balsells, J, Costello, E, Ilzarbe, L, Kleeff, J, Kong, B, Márquez, M, Mora, J, O’Driscoll, D, Scarpa, A, Ye, W, Yu, J, García-Closas, M, Kogevinas, M, Rothman, N, Silverman, D T, Albanes, D, Arslan, A A, Beane-Freeman, L, Bracci, P M, Brennan, P, Bueno-de-Mesquita, B, Buring, J, Canzian, F, PanGenEU Investigators & SBC/EPICURO Investigators 2021, ' A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer ', Genome Medicine, vol. 13, no. 1, 15 . https://doi.org/10.1186/s13073-020-00816-4
Genome Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
PanGenEU Investigators & SBC/EPICURO Investigators 2021, ' A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer ', genome medicine, vol. 13, no. 1, pp. 15 . https://doi.org/10.1186/s13073-020-00816-4
Genome Medicine, Vol 13, Iss 1, Pp 1-18 (2021)
WOS:000616492900001
RUO. Repositorio Institucional de la Universidad de Oviedo
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
The work was partially supported by Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain (PI061614, PI11/01542, PI0902102, PI12/01635, PI12/00815, PI15/01573, PI18/01347); Red Temática de Investigación Cooperativa en Cán
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28ceb522de3e324df2b13636812ee6a1
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11799
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11799
Autor:
Ma, Tempero, Jp, Arnoletti, Sw, Behrman, Ben-Josef E, Ab, Benson Rd, Es, Casper, Sj, Cohen, Czito B, Jd, Ellenhorn, Wg, Hawkins, Herman J, Jp, Hoffman, Ko A, Srinadh Komanduri, Koong A, Ww, Ma, Mp, Malafa, Nb, Merchant, Sj, Mulvihill, Nd, Muscarella P., Ek, Nakakura, Obando J, Mb, Pitman, Ar, Sasson, Tally A, Sp, Thayer, Whiting S, Ra, Wolff, Bm, Wolpin, Da, Freedman-Cass, Da, Shead, National Comprehensive Cancer Networks
Publikováno v:
Europe PubMed Central
Journal of the National Comprehensive Cancer Network : JNCCN, vol 10, iss 6
Journal of the National Comprehensive Cancer Network : JNCCN, vol 10, iss 6
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pancreatic Adenocarcinoma discuss the workup and management of tumors of the exocrine pancreas. These NCCN Guidelines Insights provide a summary and explanation of major changes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::99b0e16e0eaa2852997bf76d2119672e
http://europepmc.org/abstract/med/22679115
http://europepmc.org/abstract/med/22679115
Autor:
Oberstein PE; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York., Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Kawaler EA; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York., Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Beri N; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York., Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Enzinger P; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Perez KJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Schlechter BL; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Surana R; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Wang SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Remland J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Bollenrucher N; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Chang E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Lenehan PJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Dolgalev I; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York., Werba G; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York., Lima C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Keheler CE; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Sullivan KM; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Dougan M; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Hajdu C; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Pathology, NYU Langone Health, New York, New York., Dajee M; Novartis Institute for Biomedical Research, Cambridge, Massachusetts., Pelletier MR; Novartis Institute for Biomedical Research, Cambridge, Massachusetts., Nazeer S; Novartis Pharmaceuticals, Cambridge, Massachusetts., Squires M; Novartis Pharmaceuticals, Cambridge, Massachusetts., Bar-Sagi D; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Simeone DM; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York., Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2024 Sep 03; Vol. 12 (9), pp. 1221-1235.
Autor:
Ni Z; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland., Kundu P; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., McKean DF; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland., Wheeler W; Information Management Systems, Silver Spring, Maryland., Albanes D; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Andreotti G; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Antwi SO; Department of Quantitative Health Sciences Research, Mayo Clinic College of Medicine, Jacksonville, Florida., Arslan AA; Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York.; Department of Population Health, New York University School of Medicine, New York, New York.; Department of Environmental Medicine, New York University School of Medicine, New York, New York., Bamlet WR; Department of Quantitative Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota., Beane-Freeman LE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Bracci PM; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California., Brennan P; International Agency for Research on Cancer, Lyon, France., Buring JE; Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Gallinger S; Lunenfeld-Tanenbaum Research Institute, Sinai Health System and University of Toronto, Toronto, Canada., Gaziano JM; Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Division of Aging, Brigham and Women's Hospital, Boston, Massachusetts.; Boston VA Healthcare System, Boston, Massachusetts., Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia., Giovannucci EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Goggins MG; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, Maryland., Goodman PJ; SWOG Statistical Center, Fred Hutchinson Cancer Center, Seattle, Washington., Haiman CA; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California., Hassan MM; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Holly EA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California., Hung RJ; Lunenfeld-Tanenbaum Research Institute, Sinai Health System and University of Toronto, Toronto, Canada., Katzke V; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kooperberg C; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Kraft P; Trans-Divisional Research Program (TDRP), Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., LeMarchand L; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii., Li D; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., McCullough ML; Department of Population Science, American Cancer Society, Atlanta, Georgia., Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia., Moore SC; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Neale RE; Department of Population Health, QIMR Berghofer Medical Research Institute, Queensland, Australia., Oberg AL; Department of Quantitative Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota., Patel AV; Department of Population Science, American Cancer Society, Atlanta, Georgia., Peters U; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington., Rabe KG; Department of Quantitative Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota., Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut., Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Smith-Byrne K; Cancer Epidemiology Unit, The Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Visvanathan K; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Wactawski-Wende J; Department of Epidemiology and Environmental Health, University at Buffalo, Buffalo, New York., White E; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Department of Epidemiology, University of Washington, Seattle, Washington., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Yu H; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii., Zeleniuch-Jacquotte A; Department of Population Health, New York University School of Medicine, New York, New York.; Perlmutter Cancer Center, New York University School of Medicine, New York, New York., Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Zhong J; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Amundadottir LT; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Stolzenberg-Solomon RZ; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Klein AP; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, Maryland.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2024 Sep 03; Vol. 33 (9), pp. 1229-1239.
Autor:
Sivanand S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Gultekin Y; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Winter PS; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA., Vermeulen SY; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Tchourine KM; Department of Systems Biology, Columbia University Medical Center, New York, NY, USA., Abbott KL; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Danai LV; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA, USA., Gourgue F; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Do BT; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA., Crowder K; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Kunchok T; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Lau AN; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Darnell AM; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Jefferson A; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Morita S; Edwin L Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Duda DG; Edwin L Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Henning N; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Preclinical Imaging and Testing Facility, Massachusetts Institute of Technology, Cambridge, MA, USA., Spanoudaki V; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Preclinical Imaging and Testing Facility, Massachusetts Institute of Technology, Cambridge, MA, USA., Maiorino L; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Irvine DJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.; Ragon Institute of MGH, MITnd Harvard, Cambridge, MA, USA., Yilmaz OH; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Massachusetts General Hospital and Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA., Lewis CA; Whitehead Institute for Biomedical Research, Cambridge, MA, USA.; Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA., Vitkup D; Department of Systems Biology, Columbia University Medical Center, New York, NY, USA.; Department of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA., Shalek AK; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute of MGH, MITnd Harvard, Cambridge, MA, USA.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA., Vander Heiden MG; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. mvh@mit.edu.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. mvh@mit.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. mvh@mit.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. mvh@mit.edu.
Publikováno v:
Nature metabolism [Nat Metab] 2024 Aug 19. Date of Electronic Publication: 2024 Aug 19.
Autor:
Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. harshabad_singh@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. harshabad_singh@dfci.harvard.edu., Lowder KE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kapner K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kelly RJ; Johns Hopkins Hospital & School of Medicine, Baltimore, MD, USA.; Charles A. Sammons Cancer Center at Baylor University Medical Center, Dallas, TX, USA., Zheng H; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Chan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Regan EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Klempner SJ; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., Hannigan AM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Remland J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Andrews E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Yurgelun M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ritterhouse LL; Harvard Medical School, Boston, MA, USA.; Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Maron G; Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of Harvard and MIT, Cambridge, MA, USA., Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Gardecki E; Harvard Medical School, Boston, MA, USA.; Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Lennerz JK; Harvard Medical School, Boston, MA, USA.; Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Enzinger PC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. peter_enzinger@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. peter_enzinger@dfci.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 09; Vol. 15 (1), pp. 6833. Date of Electronic Publication: 2024 Aug 09.
Autor:
DeRidder LB; Harvard-MIT Division of Health Science Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Hare KA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Lopes A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Jenkins J; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Fitzgerald N; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., MacPherson E; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Fabian N; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Morimoto J; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Chu JN; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Harvard Medical School, Boston, MA 02115, USA; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, USA., Kirtane AR; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Madani W; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Ishida K; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Kuosmanen JLP; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Zecharias N; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Colangelo CM; Agilent Technologies, Lexington, MA 02421, USA., Huang HW; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Chilekwa M; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Lal NB; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; MIT Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Srinivasan SS; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Hayward AM; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Wolpin BM; Harvard Medical School, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA., Trumper D; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Quast T; College of Public Health, University of South Florida, Tampa, FL 33612, USA., Rubinson DA; Harvard Medical School, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA., Langer R; Harvard-MIT Division of Health Science Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA., Traverso G; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: cgt20@mit.edu.
Publikováno v:
Med (New York, N.Y.) [Med] 2024 Jul 12; Vol. 5 (7), pp. 780-796.e10. Date of Electronic Publication: 2024 Apr 24.
Autor:
Dilly J; Dana-Farber Cancer Institute, Boston, MA, United States., Hoffman MT; Dana-Farber Cancer Institute, Boston, MA, United States., Abbassi L; Dana-Farber Cancer Institute, Boston, MA, United States., Li Z; Dana-Farber Cancer Institute, Boston, MA, United States., Paradiso F; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Parent BD; Dana-Farber Cancer Institute, Boston, MA, United States., Hennessey CJ; Dana-Farber Cancer Institute, Boston, MA, United States., Jordan AC; Dana-Farber Cancer Institute, Boston, MA, United States., Morgado M; Dana-Farber Cancer Institute, Boston, MA, United States., Dasgupta S; Broad Institute, Cambridge, MA, United States., Uribe GA; Dana-Farber Cancer Institute, Boston, MA, United States., Yang A; Dana-Farber Cancer Institute, Boston, MA, United States., Kapner KS; Dana-Farber/Harvard Cancer Center, Boston, United States., Hambitzer FP; Dana-Farber Cancer Institute, Boston, MA, United States., Qiang L; Dana-Farber Cancer Institute, Boston, United States., Feng H; Dana-Farber Cancer Institute, Boston, United States., Geisberg J; Dana-Farber Cancer Institute, Boston, MA, United States., Wang J; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, United States., Evans KE; Dana-Farber Cancer Institute, Boston, MA, United States., Lyu H; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Schalck A; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Feng N; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lopez AM; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Bristow CA; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kim MP; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rajapakshe KI; The University of Texas MD Anderson Cancer Center, United States., Bahrambeigi V; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Roth JA; Broad Institute, Cambridge, MA, United States., Garg K; Resolution Bioscience, United States., Guerrero PA; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Stanger BZ; University of Pennsylvania, Philadelphia, Pennsylvania, United States., Cristea S; Dana-Farber Cancer Institute, Boston, United States., Lowe SW; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Baslan T; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Van Allen EM; Dana-Farber Cancer Institute, Boston, MA, United States., Mancias JD; Dana-Farber Cancer Institute, Boston, MA, United States., Chan E; Amgen (United States), Thousand Oaks, CA, United States., Anderson A; Amgen Inc., Thousand Oaks, CA, United States., Katlinskaya YV; Amgen Inc., Thousand Oaks, CA, United States., Shalek AK; Massachusetts Institute of Technology, Cambridge, MA, United States., Hong DS; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Pant S; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hallin J; Mirati Therapeutics (United States), San Diego, CA, United States., Anderes K; Mirati Therapeutics (United States), San Diego, CA, United States., Olson P; Mirati Therapeutics (United States), San Diego, CA, United States., Heffernan TP; The University of Texas MD Anderson Cancer Center, Houston, United States., Chugh S; Dana-Farber Cancer Institute, Boston, MA, United States., Christensen JG; Mirati Therapeutics (United States), San Diego, CA, United States., Maitra A; The University of Texas MD Anderson Cancer Center, United States., Wolpin BM; Dana-Farber/Harvard Cancer Center, Boston, MA, United States., Raghavan S; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Nowak JA; Brigham and Women's Hospital, Boston, MA, United States., Winter PS; Massachusetts Institute of Technology, Cambridge, MA, United States., Dougan SK; Dana-Farber Cancer Institute, Boston, MA, United States., Aguirre AJ; Dana-Farber Cancer Institute, Boston, MA, United States.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Jul 08. Date of Electronic Publication: 2024 Jul 08.
Autor:
Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Electronic address: chen_yuan@dfci.harvard.edu., Wang QL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Kim H; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Babic A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Zhang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Wu K; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Song M; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Ogino S; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Program in Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Cancer Immunology and Cancer Epidemiology Programs, Dana-Farber Harvard Cancer Center, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Chan AT; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Cao Y; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, Missouri; Alvin J. Siteman Cancer Center, Washington University School of Medicine in St. Louis, St. Louis, Missouri; Division of Gastroenterology, John T. Milliken Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri., Giovannucci EL; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2024 Jul; Vol. 22 (7), pp. 1508-1517.e11. Date of Electronic Publication: 2023 Sep 06.
Autor:
Wang QL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
JAMA [JAMA] 2024 May 21; Vol. 331 (19), pp. 1678-1679.